FindTrial
Sign In

Biobanking for characterization of pediatric malignancies.

'Establishing a biobank for extensive characterization of pediatric malignancie'

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
NL-OMON
Registry ID
NL-OMON21619
Enrollment
2750
Registered
2019-05-20
Start date
2017-01-31
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All patients suspected of, diagnosed with and/or treated for, or in follow-up for a pediatric malignancy at the Princess Maxima Center for pediatric oncology.

Interventions

None

Sponsors

Prinses Maxima Centrum voor kinderoncologie
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Diagnosis and/or treatment in the Princess Maxima Center. - Written informed consent according to (inter)national law and regulations

Exclusion criteria

Exclusion criteria: - Patients for whom the physicians or investigators considers that participation in this study is either not appropriate or poses unacceptable risks for the patient (e.g. when collection of additional material poses too many risks or potential harm).

Design outcomes

Primary

MeasureTime frame
Establish a biobank of patient material for future biomedical research. As such there is no formal endpoint or statistical consideration regarding the size of the biobank.—

Contacts

Public ContactDr. V. de Haas

Prinses Maxima Centrum voor kinderoncologie

v.dehaas@prinsesmaximacentrum.nl088-9729534

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)